Results 261 to 270 of about 157,912 (302)
Some of the next articles are maybe not open access.
Labetalol pharmacokinetics in pregnancy-induced hypertension
American Journal of Obstetrics and Gynecology, 1990Pharmacokinetic parameters of oral labetalol were studied in eight women with pregnancy-induced hypertension in the third trimester of pregnancy. Labetalol exhibited rapid absorption; peak serum concentrations of 881 +/- 219 ng/ml occurred at 20 minutes after labetalol ingestion.
R C, Rogers, B M, Sibai, W D, Whybrew
openaire +2 more sources
Neutrophil activation in pregnancy‐induced hypertension
BJOG: An International Journal of Obstetrics & Gynaecology, 1989Summary. Human neutrophil elastase may be a major mediator of vascular damage and could contribute to the vascular damage seen in women with pregnancy‐induced hypertension (PTH). Elevated plasma levels of this substance will reflect neutrophil activation in vivo.
I A, Greer +4 more
openaire +2 more sources
PLASMA PROLACTIN IN PREGNANCY INDUCED HYPERTENSION
BJOG: An International Journal of Obstetrics & Gynaecology, 1978SummaryIn a prospective study, plasma prolactin concentration at 37 to 41 weeks gestation in 45 primigravidae showed a significant correlation with maximal rise in diastolic blood pressure between levels at 7 to 16 weeks and those measured between 28 weeks and delivery.
D M, Jenkins, L A, Perry
openaire +2 more sources
Chronic Hypertension, Pregnancy-Induced Hypertension, and Low Birthweight
Epidemiology, 1994We examined the associations between chronic hypertension, pregnancy-induced hypertension, and low birthweight in a retrospective cohort study using Washington birth certificate data. The adjusted prevalence ratio for low birthweight associated with chronic hypertension was 3.9 [95% confidence interval (CI) = 3.4-4.4].
P, Velentgas, E, Benga-De, M A, Williams
openaire +2 more sources
Endothelial dysfunction after pregnancy‐induced hypertension
International Journal of Gynecology & Obstetrics, 2013AbstractObjectiveTo carry out long‐term analysis of the presence of endothelial dysfunction after the development of pregnancy‐induced hypertension (PIH).MethodsIn a retrospective cohort study, data were analyzed from 60 women who delivered at a tertiary maternity hospital in Fortaleza, Ceara, Brazil, between 1992 and 2002.
Ana C P T, Henriques +5 more
openaire +2 more sources
Transient Blindness in Pregnancy Induced Hypertension
Asia-Oceania Journal of Obstetrics and Gynaecology, 1994AbstractSudden blindness in pregnancy is a devastating experience for the patient, her family and the treating obstetrician. Four cases of cortical blindness with pregnancy induced hypertension are presented, seen at the General Hospital Kota Bharu, Kelantan, in 1990.
S, Achanna, D, Monga, , Sivagnanam
openaire +2 more sources
Transient blindness in pregnancy induced hypertension
International Journal of Gynecology & Obstetrics, 1989AbstractTransient blindness associated with pregnancy induced hypertension without neurological symptoms is a rare phenomenon. The blindness in these cases is postulated to be of “cortical blindness”. Two such cases occurring immediately after childbirth are presented. The ophthalmic manifestations of this complication of pregnancy induced hypertension
S, Nalliah, A S, Thavarashah
openaire +2 more sources
Immunological changes in pregnancy-induced hypertension
European Journal of Obstetrics & Gynecology and Reproductive Biology, 1994Aspects of T and B cell function were studied in women with pregnancy-induced hypertension (PIH) and normotensive pregnant women by determining the proliferation of peripheral blood mononuclear cells (PBMC) with or without stimulation by mitogens (PHA, ConA and PWM) and by determining IgG and IgM levels in the culture supernatant.
G, Chen +4 more
openaire +2 more sources
Anticardiolipin antibodies in pregnancy induced hypertension
European Journal of Obstetrics & Gynecology and Reproductive Biology, 1996It was suggested that anticardiolipin antibodies (ACA) were found positive in some obstetrical problems such as recurrent foetal losses, intrauterine growth retardation, etc. The aim of this study was to determine ACA levels in pregnancy induced hypertension (PIH) cases.
Cengiz, C +3 more
openaire +3 more sources
Pharmacologic Therapy for Pregnancy-Induced Hypertension
The Journal of Perinatal & Neonatal Nursing, 1996Complications of pregnancy-induced hypertension (PIH) remain a leading cause of maternal mortality in the United States. The etiology of the disease is not fully understood, but pathologic effects of PIH on maternal organ systems are well documented.
M C, Sisson, P M, Sauer
openaire +2 more sources